Latest Insider Transactions at Hepion Pharmaceuticals, Inc. (HEPA)
This section provides a real-time view of insider transactions for Hepion Pharmaceuticals, Inc. (HEPA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hepion Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hepion Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 27
2023
|
Peter Wijngaard Director |
BUY
Open market or private purchase
|
Direct |
2,500
+20.83%
|
$7,500
$3.05 P/Share
|
|
Nov 24
2023
|
Peter Wijngaard Director |
BUY
Open market or private purchase
|
Direct |
2,500
+26.31%
|
$7,500
$3.09 P/Share
|
|
Sep 19
2023
|
Peter Wijngaard Director |
BUY
Open market or private purchase
|
Direct |
1,000
+18.18%
|
$5,000
$5.64 P/Share
|
|
Sep 18
2023
|
Robert T Foster CEO and Director |
BUY
Open market or private purchase
|
Direct |
1,600
+3.07%
|
$8,000
$5.6 P/Share
|
|
Sep 15
2023
|
Peter Wijngaard Director |
BUY
Open market or private purchase
|
Direct |
2,000
+17.77%
|
$10,000
$5.55 P/Share
|
|
Sep 15
2023
|
Robert T Foster CEO and Director |
BUY
Open market or private purchase
|
Direct |
1,600
+3.17%
|
$8,000
$5.4 P/Share
|
|
Feb 18
2021
|
John T Cavan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+40.32%
|
$20,000
$2.0 P/Share
|
|
Feb 18
2021
|
Robert T Foster CEO and Director |
BUY
Open market or private purchase
|
Direct |
20,000
+30.65%
|
$40,000
$2.0 P/Share
|
|
Feb 16
2021
|
Peter Wijngaard Director |
BUY
Open market or private purchase
|
Direct |
10,000
+25.0%
|
$20,000
$2.2 P/Share
|
|
Dec 18
2020
|
Peter Wijngaard Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$20,000
$1.91 P/Share
|
|
Dec 08
2020
|
Robert T Foster CEO and Director |
BUY
Open market or private purchase
|
Direct |
25,000
+49.74%
|
$25,000
$1.58 P/Share
|
|
Dec 02
2020
|
John P Brancaccio Chairman |
BUY
Open market or private purchase
|
Direct |
7,000
+49.97%
|
$7,000
$1.53 P/Share
|
|
Dec 01
2020
|
Gary S Jacob Director |
BUY
Open market or private purchase
|
Direct |
12,000
+49.88%
|
$12,000
$1.66 P/Share
|
|
Nov 25
2020
|
John T Cavan Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,500
+48.39%
|
$4,500
$1.62 P/Share
|